Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The reason for the delay in the use of the second facility is all about supply chain and production management.(Link to definition)The second facility could be up and running but it is not financially in their best interest to manufacture product out of the second facility as it is currently cheaper to run one facility instead of two. As the economies of scale change (Link to definition) it will become financially beneficial to have two facilities operating.
Unfortunately, ELTP has outside forces(Government) dictating when their products come online. They are definitely banking on more than hope in paying the lease on the second facility. They know that with the products in their pipeline and the unpredictability of the FDA the second facility could be needed at a moments notice.
do we know for sure the new facility is up and running?
umm .05 to .09 is an 80% gain.
You can probably get your money back by following Renfro to his next company. He has an opt out clause in his sale of "assets". My guess is he will cut ties with FXPT and try to sell his "assets" to another company looking for a quick P&D. Set up your google alerts for James Renfro and put your money in early before the pump starts.
On January 5, 2012, the Company entered into an Amendment to the Purchase and Sale Agreement for the acquisition of Renfro Energy LLC and Cameron Parish Pipelines LLC. Pursuant to the Amendment, the parties agreed that the consideration to be issued for the acquisition would be 30,000,000 shares of the Company’s restricted common stock. Additionally, the seller has the option to re-purchase 100% of the membership interests of Renfro Energy LLC and Cameron Parish Pipelines LLC for the 30,000,000 shares of the Company’s common stock on or before April 5, 2012.
ok, how does IHUB have the first two trades of the day going for .08 with a Bid of .08 and an ask of .075? Then the third trade executing at .0945 with the same bid and ask?
Hike it may surprise you to learn that I agree with just about everything you said
sorry that was a typo. I updated it, thank you
got it. thank you
So there are still 1812.5 Series E shares remaining?
Can someone help me with this?
There were 5 conversions of 1300 Series E preferred shares for a total of 6500 shares. Yet the latest 10Q says there are only 3,112.5 Series E preferred shares. What am I missing here?
http://www.sec.gov/Archives/edgar/data/1053369/000114420412008039/v301334_10q.htm
-$600 cash on hand at year end
As of December 31, 2011, we had cash reserves of $0.6 million.
Thank you for mitigating the importance of the debt. I wasn't even a little worried, but your reassurance makes me feel even better. It is clear to me that the NJEDA bond debts will be re-worked and it will be reported as a "good news" 8k. Can't wait!
Thank you dr lowenstein for the confirmation of my beliefs
dr_lowenstein
Share
Tuesday, February 21, 2012 11:53:07 PM
Re: packerfanbud post# 12438
Post # of 12441
Like any lender they do not want to see their loans go into BK,"
great to see you agree that the NJEDA would not want to see a business such as ELTP go bankrupt. That makes me feel a lot better about their situation. Clearly things are looking up!
Isn't that the point of issuing the bonds in the first place? They are attempting to promote growing businesses. In either instance wouldn't they eliminate companies from eligibility if they are in default and they felt they could not ultimately pay?
I think I understand perfectly.
"The New Jersey Economic Development Authority (EDA) determines eligibility" (from your post)
would they determine someone to be eligible if they were never going to pay back the money that they owed to the NJEDA?
that was a fair enough statement, although I find it hard to believe that ELTP hasn't shown that is moving in the right direction. So I'm happy to hear that you agree that ELTP will go up in the near future.
As far as making money on ELTP. It will continue to go down until the next event. It really has nothing to do with the company as whole, just how it is traded. When the next event is announced it will easily go up 40-50%. It is hard to figure out when to sell in this case because there are so many events that should happen in the upcoming months but you will many opportunities to sell. Worst case scenario you buy in now and it goes up and down several times in the upcoming months and finally investors take over the traders. Either way you make money.
If someone owed you $3.4 Million would you pay them $486,801 in cash if you felt they weren't going to pay? Seems like that would be a big mistake on the part of the NJEDA...
Clearly you are convinced on something about ELTP, otherwise you wouldn't spend so much time telling people how horrible it is. You use the term "general investing public", but didn't mention the "general trading public". Right now the general trading public is winning. the PRs are predictable and so is the trading after they are issued. I believe that the trading/investing public will trend toward pps growth when ELTP shows profitability for at least back to back quarters.
I'm certain ELTP is working out for you as you are "trading from time to time". I'll even go on the record and state that as we drift on low volume waiting for the next PR I'm increasing my profit because I haven't bought back in yet from the last time I sold my trading shares. The influence that traders have on ELTP is allowing me to increase the number of shares I own. Unfortunately, I believe that will end in the next 6-9 months.
it is very telling how the financials are setting up for profits. There isn't anything on the horizon that indicates ELTP will not be profitable in upcoming quarters.
I was originally going to do quarter by quarter, but I was lazy and found all those years in 2 10ks. I can go back though the quarterlies and chart them out. Although it will take me a few days.
well, I included it in revenue. Thought it would go under "other". Either way it will go toward their bottom line. I'm not an accountant so I'll defer to anyone that wants to place the payment. So for clarity the most recent chart may not be 100% accurate according to accountants... doesn't matter because the trend clearly shows a company headed for profits.
notice after 9 months the GP is higher than last year, and double what it was when Treppel took over.
If you want to ignore everything I've said. Then yes.
do you mean the $ for NJEDA? It is in the latest 10Q
Sale of New Jersey State Net Operating Losses
In January 2012, the Company received final approval from the NJEDA for the sale of New Jersey net operating losses with net tax benefits equal to $529,132 under the Technology Business Tax Certificate Transfer Program. The Company sold the net operating loss approved for sale at a transfer price equal to ninety two cents equal to every benefit dollar. The proceeds of such sale, totaling $486,801, were received by the Company during January 2012.
I'll make an attempt to address these. If I miss something it isn't because I'm dodging it. I just don't care enough to be really detailed...
NJEDA bonds are a concern, although they are nothing new within the last year which is what I was referring to. The reason I'm not concerned at all about the bonds being in default is due to the fact that NJEDA just gave ELTP $486,801. If they were concerned about the debt wouldn't they simply take that money as payment? This tells me that something will be worked out soon, and will result in an 8k with positive results.
http://www.sec.gov/Archives/edgar/data/1053369/000114420412008039/v301334_10q.htm
Sale of New Jersey State Net Operating Losses
In January 2012, the Company received final approval from the NJEDA for the sale of New Jersey net operating losses with net tax benefits equal to $529,132 under the Technology Business Tax Certificate Transfer Program. The Company sold the net operating loss approved for sale at a transfer price equal to ninety two cents equal to every benefit dollar. The proceeds of such sale, totaling $486,801, were received by the Company during January 2012.
Finally, the type of material internal control weakness is significantly related to the probability of a firm restating its earnings. This study finds that companies that report material weakness in accounting related areas such as accruals, revenue recognition, period-end closings and accounting policies, and complex areas such as derivative and lease accounting, are more likely to restate earnings than those companies reporting material weakness in non-accounting areas such as training, segregation of duties, senior management, and subsidiary specific areas. T
Read more: http://readperiodicals.com/201107/2439605491.html#b#ixzz1n4lt6N1C
low volume down ticks due to traders and history of not being profitable. I thought that was clear. Showing a profit for continuous quarters will change the behavior of traders/investors. Every indication is that ELTP will continue their move toward profitability. Since Lodrane was removed and a few delays in bringing products to market a year ago there hasn't been a single negative event for ELTP. In fact they weathered the loss of Lodrane and delay of products remarkably well.
Also, you are correct. by nature penny stocks are highly risky. Please stop holding ELTP up to the standards of Abbott and Pfizer. Although, compared to other penny stocks ELTP stacks up very well. Comparatively speaking there isn't one single aspect of ELTP that concerns me in respect to a bright future.
Not even remotely concerned. The problem with ELTP is that they are easily manipulated since they have lost money for years. Over the last three years they have diligently worked their way toward profitability. Each and every 8k and PR sees an uptick in pps, which is sadly followed by the inevitable down slide. This stock is an ATM for traders and it will take several quarters of profitability or a really big 8k/PR to push them significantly higher.
There is a lot of money to be made here. Keep a core position and also buy and sell at lows and highs. Whenever the next PR comes, and there are many on the horizon, I'll buy back in for my trading position. I'll give it several days to determine if the run will continue and then sell a portion of my trading shares, or maybe all of them. It is almost impossible not to make money with ELTP.
Ultimately, ELTP will be profitable continuously and it will override the traders on the pps. It will take time, but the set up is in place and being executed appropriately.
Perhaps your concerns have been dismissed because people do not believe they are valid reasons not to buy ELTP?
I always like using Businessweek as a source for relationships between companies. May not always be up to date, but there is some good information out there.
http://investing.businessweek.com/research/stocks/people/relationship.asp?personId=54535388&ticker=ELTP:US&previousCapId=52171677&previousTitle=Epic%20Pharma%2C%20LLC
He has taken a company with a history of $10 million+ losses each year to the brink of profitability. The next fiscal year will be profitable. I don't know what else he could have done.
Exactly, Treppel didn't like how the previous CEO was running the day to day operations. He assumed responsibility and the efficiency of operations began improving immediately.
http://www.ehow.com/info_7778670_difference-between-ceo-chairman-board.html
The Difference Between a CEO & a Chairman of the Board
By John Lister, eHow Contributor
Print this article
When the question of who is in charge of a company arises, the answer is not always clear. There are in fact two major roles within the firm: the CEO, who is in charge of making decisions about the running of the company, and the chairman of the board of directors, who oversees -- and sometimes overrules -- the CEO's decisions. Some firms also have a chief operating officer role for day-to-day management.
Related Searches:
CEO PositionBank CEO Jobs
Chairman
The chairman is the head of a company's board of directors. In this role, the chairman effectively acts as the senior representative of shareholders and is responsible for upholding their interests. In the purest interpretation of company principles, the profitability of the company is the sole interest of the shareholders. In practice, the board of directors might also be expected to distinguish between the need to maximize profits in the immediate term, and the need to avoid actions that could harm the company's long-term stability and thus its ability to make profits in the future.
CEO
The chief executive officer's role is to be the senior decision-maker. In most cases this involves overseeing departmental managers -- overruling them where the CEO feels necessary -- while taking personal charge of major strategy decisions such as identifying and targeting audiences, changing marketing strategies or even taking over other companies.
Relationship
The CEO effectively can be said to be running the company and is usually seen as the top person within the company. However, this power and status derives from the way the CEO role is carried out. The chairman holds superiority to the CEO. As well as having the right to overrule the CEO on major issues, the chairman -- along with the rest of the board -- makes the decision to hire or fire a CEO. The exact balance of power between a CEO and a chairman can vary from company to company. For example, in some companies, departmental heads are automatically members of the board of directors; the CEO can thus exercise some influence over the make-up of the board. It is possible for the same person to hold the role of chairman and CEO within a company. There is a strong argument that this promotes a conflict of interest and limits accountability, particularly in publicly traded companies.
Read more: The Difference Between a CEO & a Chairman of the Board | eHow.com http://www.ehow.com/info_7778670_difference-between-ceo-chairman-board.html#ixzz1mya5RdAS
Thank you!
ELTP is financially on the right path. They weathered the loss of lodrane by continuing to add products. Treppel has done a great job of reducing the operating loss significantly. Each year getting closer to a profit. Depending on milestone payments that may be triggered in the next month it is possible fiscal year 2012 will be profitable (you can already add in $486,801 from NJEDA). 2013 will be for sure.
I think you really don't understand buying OTC stocks. Every single one of them has zero history in regards to profits. That is why they are not on the big boards. If you want verified history then invest in Pfizer and Abbott. There is no reason to tell everyone that ELTP isn't a blockbuster, it is trading around a dime, we get it. Those investing are banking on the future. that is what otc stocks are about.
did you really invest in a company without reading all of their filings?
http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=eltp&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Thank you for the "big warning". I had always been under the assumption that 10qs were submitted prior to being audited as the process is expensive and time consuming. So I checked a few other company's most recent 10qs or 10k. I even kept it industry specific. Just shocking to find all these unaudited filings. They must be hiding something, right?
Pfizer
http://sec.gov/Archives/edgar/data/78003/000115752311006714/a50063064.htm
Abbott
http://sec.gov/Archives/edgar/data/1800/000110465911061064/a11-25611_110q.htm
Merck
http://sec.gov/Archives/edgar/data/64978/000095012310030079/y83548e10vk.htm
Has the actual dollar value of the New Jersey Tax Ceetificate Transfer been made public prior to the release of the 10Q? I only remember seeing $800k in tax credits. Looks like this puts almost $500k in the bank for them.
Sale of New Jersey State Net Operating Losses
In January 2012, the Company received final approval from the NJEDA for the sale of New Jersey net operating losses with net tax benefits equal to $529,132 under the Technology Business Tax Certificate Transfer Program. The Company sold the net operating loss approved for sale at a transfer price equal to ninety two cents equal to every benefit dollar. The proceeds of such sale, totaling $486,801, were received by the Company during January 2012.
not really sure what your issue is? I'm not advocating the purchase of BRZL, I'm merely stating that a clean shell has value. Why wouldn't Weiss come back to it? He is the CEO, not an ex-husband bitter after a divorce. There is money to be made when he is ready.